Denver, Colorado - As Wall Street heads into the final hour of trading, momentum is clustering around quantum computing, next-gen biomaterials, vaccine platforms, and digital asset strategy plays. Today’s tape is being defined by revenue beats, national infrastructure deployments, major licensing deals, and one headline-grabbing magazine cover that has small-cap traders leaning forward into the bell.
Kraig Biocraft Laboratories on NatGeo Cover
Shares of Kraig Biocraft Laboratories (OTCQB:KBLB) are drawing speculative attention after the company’s recombinant spider silk technology landed on the cover of the March 2026 issue of National Geographic.
The feature spotlights Kraig Labs’ genetically enhanced silkworm platform engineered to produce spider silk fibers through scalable sericulture processes. During National Geographic’s on-site visit, demonstrations included towing a car across a parking lot and suspending a person using a single 0.35-ounce loop of thread, visual proof points underscoring the material’s strength-to-weight profile.
The exposure comes as Kraig signals production ramp initiatives targeting apparel, industrial, medical, and defense markets. Visibility milestones often act as narrative accelerants in emerging materials stories, and traders will be watching volume into the close for confirmation of sustained momentum.
Antelope Enterprise Holdings- $BTC Strategy into Volatility
Crypto-linked equities are seeing speculative flows after Antelope Enterprise Holdings (NASDAQ:AEHL) launched its structured digital asset strategy dubbed the “Genius Plan.”
The framework begins with a $1 million Bitcoin allocation, deploying capital in tranches while activating a 1% incremental profit-harvesting model designed to recycle gains—50% of which are earmarked for share repurchases.
CEO Tingting Zhang described the plan as building “a structured capital loop connecting digital assets and equity markets.”
With Bitcoin volatility elevated, traders are watching AEHL into the close for sympathy moves tied to broader crypto price swings.
IonQ Full-Stack Quantum Momentum Builds
It’s been a heavyweight session for IonQ (NYSE:IONQ) after the company reported $130.0 million in full-year 2025 GAAP revenue, up 202% year over year, becoming the first public quantum company to surpass $100 million in annual GAAP revenue.
Fourth-quarter revenue hit $61.9 million, exceeding guidance by 55% at the midpoint. The company ended the year with $3.3 billion in cash, equivalents, and investments, giving it one of the strongest balance sheets in the emerging quantum sector.
IonQ also announced an agreement to acquire SkyWater Technology, aiming to create a well-capitalized merchant supplier for the U.S. quantum ecosystem. Management stated the company has evolved into a “full-stack quantum platform company” spanning computing, networking, sensing, and security.
Separately, IonQ deployed Romania’s National Quantum Communication Infrastructure—one of Europe’s largest terrestrial quantum key distribution (QKD) networks, further solidifying its global footprint.
With 2026 revenue guidance between $225 million and $245 million, IonQ remains firmly on momentum watch into the after-hours session.
Butterfly Network- Record Revenue and Cash Flow Inflection
Butterfly Network (NYSE:BFLY) delivered record fourth-quarter revenue of $31.5 million, up 41% year over year, while achieving its first quarter of positive operating cash flow in company history.
Gross margin expanded to 67.3%, supported in part by higher-margin licensing revenue from its Butterfly Embedded™ platform. The company also highlighted a $6.8 million Q4 revenue contribution from its co-development partnership with Midjourney.
CEO Joseph DeVivo said the company is transitioning “from a medical device company into a transformative semiconductor-based company,” emphasizing its Ultrasound-on-Chip™ foundation.
With $150.5 million in cash and 2026 revenue guidance of $117–$121 million, BFLY enters the final hour as a potential continuation setup if buyers defend gains.
Novavax- Licensing Leverage and Milestone Engine
Biotech traders are closely monitoring Novavax, Inc. (NASDAQ:NVAX) after reporting $1.1 billion in full-year 2025 revenue, up 65% year over year, and swinging to full-year net income of $440 million.
Key catalysts include a January 2026 non-exclusive Matrix-M® adjuvant licensing agreement with Pfizer, featuring a $30 million upfront payment and potential milestone payments of up to $500 million, plus royalties. Novavax also earned $225 million in milestones under its Sanofi partnership during 2025.
CEO John C. Jacobs stated the company made “significant progress on our corporate strategy,” highlighting partnerships and expanded material transfer agreements.
With $751 million in cash at year-end and a new $330 million credit facility secured in February, NVAX remains a licensing-driven biotech story with multiple partnership levers in play.
Rackspace Technology- Hybrid Cloud Inflection
Rackspace Technology (NASDAQ:RXT) reported Q4 revenue of $683 million, with Public Cloud revenue rising 6% year over year while Private Cloud declined 10%.
Full-year net loss narrowed significantly to $(226) million from $(858) million in 2024, and Non-GAAP Operating Profit rose 19% for the year.
Management emphasized AI as an emerging growth vector layered onto its hybrid cloud foundation, guiding 2026 revenue between $2.6 billion and $2.7 billion.
Cloud stabilization narratives can gain traction quickly if buyers interpret 2025 as the trough year.
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
About 24/7 Market News
In today's fast-moving markets, visibility is everything and 24/7 Market News (24/7) provides a powerful suite of investor relations and public relations solutions designed to elevate your company’s profile quickly and effectively. Whether you're an established name seeking broader awareness, or a micro-cap looking to break out of obscurity, 24/7 delivers targeted, high-impact coverage through timely news distribution, analyst report placements, featured editorials, and multi-channel amplification across financial platforms, social media, and investor communities. Our services help cut through the noise, attract institutional interest, drive exposure, and build long-term shareholder credibility, all while maintaining full SEC compliance and transparency. For Analyst Report coverage, custom IR campaigns, press release syndication, or other tailored investor and public relations solutions, contact sales@247marketnews.com to discuss how 24/7 can help accelerate your company’s visibility and valuation trajectory.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 24/7 is a third-party media provider that owns KBLB shares, which are on deposit and may be sold at the editor’s discretion, and has been compensated for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.
For further information, please visit 247marketnews.com or https://go.247marketnews.com/kblb-disclosure/
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.